FRED Retrospective Study of Intracranial Aneurysms Treatment
ConditionIntracranial Aneurysm
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorMicrovention-Terumo, Inc.
About this trial
To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market environment
Eligibility criteria
Qualifiers
People in China mainland who have been treated with FRED. The patients for whom clinical data are available
Disqualifiers
Patients who met the inclusion criteria at all time points were required to be included in the study. Therefore, no specific exclusion criteria were set.
Trial design
Treatments tested in this trial
- Flow Re-Direction Endoluminal Device System(FRED)
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov